GSC
EBS icon

Ground Swell Capital’s Emergent Biosolutions EBS Stock Holding History

Ground Swell Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+200
New +$4.58K 0.01% 1553

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Ground Swell Capital's EBS Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Emergent Biosolutions (EBS) in Q3 2014: 200 shares worth $4K. The stake represents 0.01% of the portfolio and ranks #1553 among its holdings.

162 funds tracked by Wall St. Rank hold EBS as of Q3 2014.

  • Ground Swell Capital held 200 shares of Emergent Biosolutions worth $4K as of Q3 2014.
  • Emergent Biosolutions was a new Ground Swell Capital position in Q3 2014.
  • Emergent Biosolutions made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1553 holding.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.